QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants

Hu, Y., et al. QS-21: Structural insights, immunological mechanisms, and prospects for rational design of safer vaccine adjuvants. Eur J Med Chem, 2026 Jan 5, 301:118223. PMID: 41046625

• This review article provides a comprehensive overview of QS-21, a potent saponin- based adjuvant derived from the bark of the soap-bark tree (Quillaja saponaria), focusing on its structural characteristics, immunological mechanisms, and potential for rational design of safer vaccine adjuvants.

• The primary goal of the paper is to explore recent advances in understanding the structure-activity relationships (SAR) of QS-21 and to investigate strategies, such as chemical synthesis and biosynthetic engineering, that could lead to the development of more stable, less toxic, and more readily available QS-21 analogs. These efforts aim to facilitate the rational design of improved adjuvants, ultimately supporting the development of more effective and safer vaccines. The review underscores the significance of these structural and mechanistic insights for future adjuvant innovation and vaccine formulation.

• Comment from DKI: The current source of QS-21 is primarily the bark of the soap- bark tree (Quillaja saponaria), as detailed in the paper. The extraction process involves pretreating the bark, followed by advanced chromatographic techniques like reversed-phase high-performance liquid chromatography (HPLC) to isolate high- purity QS-21. While the paper emphasizes the challenges associated with natural extraction, it implicitly underscores some advantages of using bark extract. Natural Origin: Extracting QS-21 directly from the soap-bark tree allows the procurement of the molecule in its naturally occurring form, which has been validated in clinical studies to possess potent adjuvant activity. Complexity of Natural Structure: The natural extract contains a mixture of saponins, including QS-21, which may work synergistically to elicit robust immune responses.

Click here to access the full scientific paper.